СOVID-19 is a systemic disease with dysfunction of the immune system and damage to internal organs, including the liver. The purpose of the study is to fnd out the impact of the SARS-CoV-2 virus on the liver, the possibility of its recovery after a coronavirus infection. We examined 112 patients with a positive test for COVID-19. А clinical examination, clinical and biochemical blood tests, computed tomography of the chest, pulse oximetry, ultrasound examination of the abdomen were performed. All patients were divided into two groups based on the presence or the absence of cytolytic syndrome. It was found that liver pathology was detected in 48.2% of patients. These changes were accompanied by statistically signifcant lower levels of oxygen in the blood and a greater amount of damage to the lung tissue, disorders of the platelet germ of hematopoiesis. Three months after a coronavirus infection with liver damage, a third of patients had cytolysis syndrome. The use of ademetionine at a dose of 800–1600 mg per day led to the elimination of clinical symptoms, normalization of the liver.Conclusion. Liver damage during coronavirus infection was common and had a hepatocellular nature, accompanied by hypoxia, increased lung tissue damage and changes in platelet count. Patients need to be examined to identify the presence of liver pathology, treatment of disorders using ademetionine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.